Lisa Cicutto
Concepts (307)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 56 | 2024 | 1800 | 5.020 |
Why?
| | School Health Services | 16 | 2024 | 218 | 4.860 |
Why?
| | School Nursing | 3 | 2018 | 34 | 1.440 |
Why?
| | Patient Education as Topic | 14 | 2015 | 770 | 1.060 |
Why?
| | Needs Assessment | 4 | 2024 | 404 | 0.910 |
Why?
| | Ontario | 20 | 2011 | 91 | 0.890 |
Why?
| | Nurses, Public Health | 2 | 2014 | 5 | 0.820 |
Why?
| | Disease Management | 6 | 2018 | 651 | 0.820 |
Why?
| | Evidence-Based Practice | 3 | 2016 | 231 | 0.780 |
Why?
| | Community Health Services | 5 | 2018 | 229 | 0.730 |
Why?
| | Program Development | 5 | 2018 | 371 | 0.680 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 5 | 2018 | 928 | 0.660 |
Why?
| | Social Determinants of Health | 1 | 2024 | 317 | 0.600 |
Why?
| | Schools | 9 | 2022 | 436 | 0.580 |
Why?
| | Colorado | 10 | 2026 | 4595 | 0.560 |
Why?
| | Self Care | 6 | 2016 | 396 | 0.530 |
Why?
| | Child | 33 | 2024 | 22693 | 0.530 |
Why?
| | Competency-Based Education | 1 | 2016 | 83 | 0.460 |
Why?
| | Particulate Matter | 1 | 2018 | 328 | 0.450 |
Why?
| | Respiratory Therapy | 1 | 2015 | 25 | 0.440 |
Why?
| | Nurse's Role | 1 | 2016 | 148 | 0.430 |
Why?
| | Frailty | 1 | 2018 | 208 | 0.430 |
Why?
| | Attitude to Health | 4 | 2007 | 421 | 0.410 |
Why?
| | Primary Health Care | 6 | 2014 | 1776 | 0.410 |
Why?
| | Practice Guidelines as Topic | 7 | 2016 | 1591 | 0.390 |
Why?
| | Ambulatory Care | 1 | 2018 | 628 | 0.380 |
Why?
| | Anaphylaxis | 2 | 2011 | 105 | 0.380 |
Why?
| | Humans | 75 | 2026 | 146342 | 0.380 |
Why?
| | Health Personnel | 3 | 2016 | 754 | 0.370 |
Why?
| | Rural Health Services | 1 | 2014 | 139 | 0.360 |
Why?
| | Medical Records | 4 | 2009 | 193 | 0.350 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 349 | 0.340 |
Why?
| | Emergency Service, Hospital | 5 | 2018 | 2363 | 0.330 |
Why?
| | Health Services Accessibility | 5 | 2024 | 1107 | 0.310 |
Why?
| | Hospitalization | 3 | 2018 | 2475 | 0.300 |
Why?
| | Occupational Diseases | 1 | 2011 | 164 | 0.300 |
Why?
| | Bronchodilator Agents | 5 | 2021 | 186 | 0.300 |
Why?
| | Urban Population | 2 | 2026 | 497 | 0.290 |
Why?
| | Child Care | 1 | 2009 | 32 | 0.290 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2015 | 1408 | 0.280 |
Why?
| | Adolescent | 20 | 2024 | 22557 | 0.280 |
Why?
| | Cost of Illness | 2 | 2008 | 323 | 0.270 |
Why?
| | Plagiarism | 1 | 2008 | 3 | 0.270 |
Why?
| | Female | 38 | 2024 | 79499 | 0.270 |
Why?
| | Population Surveillance | 1 | 2011 | 481 | 0.270 |
Why?
| | Hotlines | 1 | 2007 | 35 | 0.260 |
Why?
| | Rural Population | 2 | 2026 | 677 | 0.260 |
Why?
| | Observer Variation | 1 | 2008 | 356 | 0.250 |
Why?
| | Anti-Asthmatic Agents | 7 | 2009 | 263 | 0.250 |
Why?
| | Child, Preschool | 13 | 2024 | 11913 | 0.250 |
Why?
| | Male | 36 | 2024 | 73396 | 0.240 |
Why?
| | Public Health Nursing | 1 | 2006 | 5 | 0.240 |
Why?
| | Education, Medical, Continuing | 2 | 2005 | 130 | 0.240 |
Why?
| | Disease Progression | 3 | 2018 | 2867 | 0.240 |
Why?
| | Public Health Practice | 1 | 2006 | 63 | 0.230 |
Why?
| | Documentation | 1 | 2008 | 202 | 0.230 |
Why?
| | Program Evaluation | 4 | 2018 | 952 | 0.230 |
Why?
| | Education, Professional | 1 | 2005 | 18 | 0.230 |
Why?
| | Guidelines as Topic | 2 | 2021 | 267 | 0.220 |
Why?
| | Community Participation | 1 | 2026 | 128 | 0.210 |
Why?
| | Lung Transplantation | 2 | 2007 | 326 | 0.210 |
Why?
| | Specialization | 1 | 2005 | 137 | 0.210 |
Why?
| | Health Care Costs | 1 | 2008 | 423 | 0.210 |
Why?
| | Recurrence | 1 | 2007 | 1133 | 0.210 |
Why?
| | Certification | 1 | 2005 | 118 | 0.200 |
Why?
| | Respiratory Sounds | 1 | 2024 | 102 | 0.200 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2024 | 135 | 0.200 |
Why?
| | Climate Change | 1 | 2026 | 184 | 0.200 |
Why?
| | Adult | 27 | 2018 | 41087 | 0.200 |
Why?
| | Breath Tests | 1 | 2004 | 77 | 0.200 |
Why?
| | Pilot Projects | 3 | 2024 | 1888 | 0.190 |
Why?
| | Clinical Competence | 2 | 2016 | 1272 | 0.190 |
Why?
| | Vulnerable Populations | 1 | 2024 | 178 | 0.190 |
Why?
| | Quality of Life | 5 | 2013 | 3200 | 0.190 |
Why?
| | Biomedical Research | 2 | 2023 | 729 | 0.180 |
Why?
| | Nebulizers and Vaporizers | 2 | 2015 | 63 | 0.180 |
Why?
| | Registries | 1 | 2011 | 2400 | 0.180 |
Why?
| | Awards and Prizes | 1 | 2023 | 72 | 0.180 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 92 | 0.180 |
Why?
| | Delphi Technique | 1 | 2024 | 350 | 0.180 |
Why?
| | Employment | 1 | 2004 | 180 | 0.180 |
Why?
| | Organizational Case Studies | 2 | 2016 | 70 | 0.180 |
Why?
| | Sputum | 1 | 2004 | 302 | 0.180 |
Why?
| | Monitoring, Physiologic | 1 | 2004 | 279 | 0.170 |
Why?
| | Social Support | 4 | 2011 | 646 | 0.170 |
Why?
| | Depression | 1 | 2011 | 1575 | 0.170 |
Why?
| | Albuterol | 1 | 2021 | 76 | 0.170 |
Why?
| | Parents | 3 | 2024 | 1394 | 0.170 |
Why?
| | Attitude of Health Personnel | 2 | 2009 | 1219 | 0.160 |
Why?
| | Health Services | 3 | 2013 | 112 | 0.160 |
Why?
| | Bronchial Neoplasms | 1 | 2000 | 15 | 0.160 |
Why?
| | Surveys and Questionnaires | 11 | 2015 | 6073 | 0.160 |
Why?
| | Carcinoma, Mucoepidermoid | 1 | 2000 | 17 | 0.160 |
Why?
| | Adaptation, Psychological | 2 | 2010 | 721 | 0.160 |
Why?
| | Lung Diseases | 2 | 2022 | 787 | 0.160 |
Why?
| | Societies, Medical | 1 | 2024 | 907 | 0.150 |
Why?
| | Family | 3 | 2018 | 690 | 0.150 |
Why?
| | Health Equity | 1 | 2022 | 139 | 0.150 |
Why?
| | Absenteeism | 3 | 2018 | 51 | 0.150 |
Why?
| | Connecticut | 1 | 2018 | 25 | 0.140 |
Why?
| | Population | 1 | 2018 | 30 | 0.140 |
Why?
| | Hypersensitivity | 2 | 2011 | 253 | 0.140 |
Why?
| | Case Management | 1 | 2018 | 66 | 0.140 |
Why?
| | Middle Aged | 15 | 2018 | 36619 | 0.130 |
Why?
| | Health Policy | 1 | 2021 | 399 | 0.130 |
Why?
| | Students | 2 | 2014 | 649 | 0.130 |
Why?
| | Health Services Needs and Demand | 2 | 2011 | 287 | 0.130 |
Why?
| | Qualitative Research | 2 | 2024 | 1734 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 4 | 2000 | 1408 | 0.130 |
Why?
| | Pulmonary Medicine | 3 | 2024 | 78 | 0.120 |
Why?
| | Nursing Education Research | 1 | 2016 | 43 | 0.120 |
Why?
| | Occupational Exposure | 2 | 2011 | 356 | 0.120 |
Why?
| | Peripheral Arterial Disease | 1 | 2023 | 507 | 0.120 |
Why?
| | Aged | 11 | 2018 | 26432 | 0.110 |
Why?
| | Education, Graduate | 1 | 2015 | 35 | 0.110 |
Why?
| | Biomarkers | 2 | 2024 | 4340 | 0.110 |
Why?
| | Mass Screening | 1 | 2024 | 1307 | 0.110 |
Why?
| | Patient Participation | 1 | 1999 | 457 | 0.110 |
Why?
| | Research Personnel | 2 | 2015 | 190 | 0.110 |
Why?
| | Health Education | 2 | 2009 | 346 | 0.110 |
Why?
| | Information Dissemination | 2 | 2015 | 226 | 0.110 |
Why?
| | Administration, Inhalation | 2 | 2015 | 567 | 0.100 |
Why?
| | Epinephrine | 2 | 2011 | 160 | 0.100 |
Why?
| | Education, Continuing | 1 | 2014 | 42 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1272 | 0.100 |
Why?
| | Interviews as Topic | 3 | 2024 | 930 | 0.100 |
Why?
| | Diabetes Complications | 1 | 2015 | 219 | 0.090 |
Why?
| | Drug Utilization | 1 | 2013 | 171 | 0.090 |
Why?
| | Health Services Research | 1 | 2015 | 390 | 0.090 |
Why?
| | Universities | 1 | 2015 | 451 | 0.090 |
Why?
| | Severity of Illness Index | 4 | 2008 | 2921 | 0.090 |
Why?
| | Mentors | 3 | 2023 | 217 | 0.090 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2015 | 265 | 0.090 |
Why?
| | Activities of Daily Living | 2 | 2006 | 442 | 0.090 |
Why?
| | Motivation | 3 | 2007 | 605 | 0.090 |
Why?
| | Socioeconomic Factors | 2 | 2013 | 1327 | 0.080 |
Why?
| | Respiratory Function Tests | 3 | 2024 | 543 | 0.080 |
Why?
| | Healthcare Disparities | 1 | 2018 | 733 | 0.080 |
Why?
| | Quality Indicators, Health Care | 1 | 2014 | 343 | 0.080 |
Why?
| | Medication Adherence | 1 | 2015 | 535 | 0.080 |
Why?
| | General Surgery | 1 | 2013 | 217 | 0.080 |
Why?
| | Infant | 5 | 2024 | 10114 | 0.080 |
Why?
| | Internet | 2 | 2011 | 660 | 0.080 |
Why?
| | Risk Factors | 5 | 2023 | 10921 | 0.080 |
Why?
| | Health Services Administration | 1 | 2009 | 9 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2013 | 355 | 0.070 |
Why?
| | Health Promotion | 1 | 2016 | 786 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2008 | 3416 | 0.070 |
Why?
| | Young Adult | 2 | 2018 | 14330 | 0.070 |
Why?
| | Suction | 1 | 2009 | 31 | 0.070 |
Why?
| | Nursing Methodology Research | 2 | 2007 | 43 | 0.070 |
Why?
| | Demography | 1 | 2009 | 274 | 0.070 |
Why?
| | Age Factors | 2 | 2007 | 3347 | 0.070 |
Why?
| | Curriculum | 3 | 2015 | 1079 | 0.070 |
Why?
| | Food Hypersensitivity | 1 | 2010 | 165 | 0.070 |
Why?
| | Delivery of Health Care | 2 | 2022 | 947 | 0.070 |
Why?
| | Scientific Misconduct | 1 | 2008 | 8 | 0.070 |
Why?
| | Canada | 5 | 2011 | 432 | 0.070 |
Why?
| | Quality Control | 1 | 2008 | 163 | 0.070 |
Why?
| | Risk | 1 | 2010 | 920 | 0.070 |
Why?
| | Databases as Topic | 1 | 2007 | 70 | 0.070 |
Why?
| | Information Services | 1 | 2007 | 42 | 0.070 |
Why?
| | Cross-Sectional Studies | 3 | 2009 | 5899 | 0.060 |
Why?
| | Health Status Indicators | 1 | 2007 | 167 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2011 | 1135 | 0.060 |
Why?
| | Circadian Rhythm | 5 | 1992 | 515 | 0.060 |
Why?
| | Informed Consent | 1 | 2007 | 195 | 0.060 |
Why?
| | Employee Performance Appraisal | 1 | 2005 | 6 | 0.060 |
Why?
| | Family Practice | 2 | 2000 | 422 | 0.060 |
Why?
| | Child Welfare | 1 | 2007 | 229 | 0.060 |
Why?
| | Seasons | 1 | 2008 | 540 | 0.050 |
Why?
| | Health Plan Implementation | 1 | 2006 | 143 | 0.050 |
Why?
| | Community-Based Participatory Research | 1 | 2026 | 172 | 0.050 |
Why?
| | Telephone | 1 | 2005 | 175 | 0.050 |
Why?
| | Counseling | 1 | 2007 | 406 | 0.050 |
Why?
| | Leukotriene Antagonists | 1 | 2004 | 24 | 0.050 |
Why?
| | Patient Admission | 1 | 2006 | 216 | 0.050 |
Why?
| | Decision Making | 2 | 2011 | 993 | 0.050 |
Why?
| | Health Surveys | 1 | 2006 | 511 | 0.050 |
Why?
| | Adrenergic beta-Agonists | 1 | 2004 | 91 | 0.050 |
Why?
| | Europe | 1 | 2024 | 421 | 0.050 |
Why?
| | Financing, Organized | 1 | 2023 | 36 | 0.050 |
Why?
| | Atherectomy | 1 | 2023 | 37 | 0.050 |
Why?
| | Vascular Patency | 1 | 2023 | 115 | 0.050 |
Why?
| | Advisory Committees | 1 | 2024 | 228 | 0.050 |
Why?
| | Popliteal Artery | 1 | 2023 | 60 | 0.050 |
Why?
| | Internship and Residency | 1 | 2013 | 1281 | 0.050 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 64 | 0.050 |
Why?
| | Patient Care Team | 1 | 2008 | 701 | 0.050 |
Why?
| | Theophylline | 4 | 1992 | 41 | 0.050 |
Why?
| | Parent-Child Relations | 1 | 2005 | 266 | 0.050 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2023 | 147 | 0.050 |
Why?
| | United States | 4 | 2023 | 16136 | 0.040 |
Why?
| | Faculty | 1 | 2023 | 152 | 0.040 |
Why?
| | Femoral Artery | 1 | 2023 | 183 | 0.040 |
Why?
| | Educational Status | 1 | 2004 | 466 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2023 | 11821 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2006 | 568 | 0.040 |
Why?
| | Chronic Disease | 1 | 2007 | 1827 | 0.040 |
Why?
| | Focus Groups | 1 | 2004 | 588 | 0.040 |
Why?
| | Spirometry | 2 | 2000 | 234 | 0.040 |
Why?
| | Obesity | 1 | 2015 | 3131 | 0.040 |
Why?
| | Risk Assessment | 2 | 2007 | 3712 | 0.040 |
Why?
| | Guideline Adherence | 2 | 2008 | 594 | 0.040 |
Why?
| | Self Efficacy | 1 | 2004 | 418 | 0.040 |
Why?
| | Physicians | 1 | 2009 | 955 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2004 | 474 | 0.040 |
Why?
| | Patient Compliance | 1 | 2004 | 589 | 0.040 |
Why?
| | Peer Group | 2 | 2011 | 251 | 0.040 |
Why?
| | Cooperative Behavior | 2 | 2015 | 471 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 883 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2000 | 541 | 0.040 |
Why?
| | Time Factors | 3 | 2007 | 7109 | 0.030 |
Why?
| | Health Status | 1 | 2004 | 827 | 0.030 |
Why?
| | Physicians, Family | 1 | 2000 | 179 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2008 | 5439 | 0.030 |
Why?
| | Poverty | 1 | 2022 | 530 | 0.030 |
Why?
| | Mental Health | 1 | 2004 | 779 | 0.030 |
Why?
| | Critical Care | 1 | 2004 | 706 | 0.030 |
Why?
| | Cohort Studies | 1 | 2008 | 6077 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3206 | 0.030 |
Why?
| | Research Design | 1 | 2022 | 1143 | 0.030 |
Why?
| | Models, Educational | 1 | 2015 | 91 | 0.030 |
Why?
| | Capacity Building | 1 | 2015 | 61 | 0.030 |
Why?
| | Prospective Studies | 1 | 2007 | 8123 | 0.030 |
Why?
| | Research Support as Topic | 1 | 2015 | 83 | 0.030 |
Why?
| | Data Collection | 2 | 2009 | 650 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 200 | 0.030 |
Why?
| | Inflammation | 2 | 2004 | 2919 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6460 | 0.020 |
Why?
| | Histamine | 1 | 1991 | 52 | 0.020 |
Why?
| | Art | 1 | 2010 | 13 | 0.020 |
Why?
| | Receptors, Adrenergic, beta | 1 | 1991 | 58 | 0.020 |
Why?
| | Public Policy | 1 | 2010 | 79 | 0.020 |
Why?
| | Risk Management | 1 | 2010 | 81 | 0.020 |
Why?
| | Psychology | 1 | 2010 | 85 | 0.020 |
Why?
| | Longitudinal Studies | 2 | 2008 | 3017 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2023 | 17438 | 0.020 |
Why?
| | Respiratory Tract Diseases | 1 | 1991 | 178 | 0.020 |
Why?
| | Ethanolamines | 1 | 1989 | 14 | 0.020 |
Why?
| | Forced Expiratory Volume | 4 | 1992 | 451 | 0.020 |
Why?
| | Social Behavior | 1 | 2011 | 279 | 0.020 |
Why?
| | Adrenergic Agonists | 1 | 2008 | 5 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1991 | 303 | 0.020 |
Why?
| | Morbidity | 1 | 2009 | 319 | 0.020 |
Why?
| | Self Administration | 1 | 2008 | 121 | 0.020 |
Why?
| | Morale | 1 | 2007 | 5 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2009 | 368 | 0.020 |
Why?
| | Perception | 1 | 2010 | 373 | 0.020 |
Why?
| | Career Choice | 1 | 2009 | 237 | 0.020 |
Why?
| | Insurance, Health | 1 | 2009 | 318 | 0.010 |
Why?
| | Insulin Resistance | 1 | 2015 | 1247 | 0.010 |
Why?
| | Quality Improvement | 1 | 2015 | 1354 | 0.010 |
Why?
| | Forms and Records Control | 1 | 2006 | 21 | 0.010 |
Why?
| | Body Mass Index | 1 | 2015 | 2458 | 0.010 |
Why?
| | Education | 1 | 2006 | 103 | 0.010 |
Why?
| | Acute Disease | 1 | 2008 | 1038 | 0.010 |
Why?
| | Adrenal Cortex Hormones | 1 | 2008 | 486 | 0.010 |
Why?
| | Age Distribution | 1 | 2006 | 399 | 0.010 |
Why?
| | Emotions | 1 | 2010 | 559 | 0.010 |
Why?
| | Sex Distribution | 1 | 2006 | 382 | 0.010 |
Why?
| | Teaching | 1 | 2007 | 244 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2009 | 1998 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2008 | 731 | 0.010 |
Why?
| | Double-Blind Method | 2 | 2006 | 2070 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2008 | 536 | 0.010 |
Why?
| | Respiration, Artificial | 1 | 2009 | 711 | 0.010 |
Why?
| | Oxygen | 1 | 2009 | 997 | 0.010 |
Why?
| | Databases, Factual | 1 | 2009 | 1493 | 0.010 |
Why?
| | Pharmacies | 1 | 2004 | 40 | 0.010 |
Why?
| | Patient Selection | 1 | 2007 | 728 | 0.010 |
Why?
| | Decision Support Techniques | 1 | 2007 | 478 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2009 | 1763 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2008 | 881 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2004 | 314 | 0.010 |
Why?
| | Peak Expiratory Flow Rate | 2 | 1992 | 25 | 0.010 |
Why?
| | Methacholine Chloride | 2 | 1992 | 50 | 0.010 |
Why?
| | Bronchial Provocation Tests | 2 | 1992 | 46 | 0.010 |
Why?
| | Patient Readmission | 1 | 2006 | 778 | 0.010 |
Why?
| | Health Behavior | 1 | 2005 | 802 | 0.010 |
Why?
| | Sleep Stages | 2 | 1989 | 76 | 0.010 |
Why?
| | Lung | 1 | 1992 | 4122 | 0.010 |
Why?
| | Communication | 1 | 2005 | 980 | 0.010 |
Why?
| | Random Allocation | 2 | 1989 | 366 | 0.010 |
Why?
| | Delayed-Action Preparations | 2 | 1989 | 192 | 0.010 |
Why?
| | Sleep | 2 | 1991 | 896 | 0.010 |
Why?
| | Pindolol | 1 | 1991 | 2 | 0.010 |
Why?
| | Radioligand Assay | 1 | 1991 | 35 | 0.010 |
Why?
| | Bronchoconstriction | 1 | 1991 | 29 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1991 | 185 | 0.010 |
Why?
| | Isoproterenol | 1 | 1991 | 96 | 0.000 |
Why?
| | Cell Count | 1 | 1991 | 315 | 0.000 |
Why?
| | Leukocyte Count | 1 | 1991 | 321 | 0.000 |
Why?
| | Methacholine Compounds | 1 | 1990 | 1 | 0.000 |
Why?
| | Cyclic AMP | 1 | 1991 | 208 | 0.000 |
Why?
| | Cell Separation | 1 | 1991 | 300 | 0.000 |
Why?
| | Bronchoscopy | 1 | 1991 | 227 | 0.000 |
Why?
| | Drug Evaluation | 1 | 1989 | 78 | 0.000 |
Why?
| | Sodium Chloride | 1 | 1990 | 138 | 0.000 |
Why?
| | Leukocytes | 1 | 1991 | 301 | 0.000 |
Why?
| | Pulmonary Gas Exchange | 1 | 1989 | 117 | 0.000 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 1991 | 588 | 0.000 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 1991 | 642 | 0.000 |
Why?
| | Bronchi | 1 | 1990 | 263 | 0.000 |
Why?
| | Administration, Oral | 1 | 1989 | 872 | 0.000 |
Why?
| | Dose-Response Relationship, Drug | 1 | 1989 | 2022 | 0.000 |
Why?
| | Clinical Trials as Topic | 1 | 1989 | 1064 | 0.000 |
Why?
|
|
Cicutto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|